3/12
08:01 am
ngm
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.
Low
Report
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.
3/12
08:01 am
ngm
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.
Low
Report
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.
3/12
05:23 am
ngm
Rating for NGM
Report
Rating for NGM
3/12
05:23 am
ngm
Rating for NGM
Report
Rating for NGM
3/12
04:44 am
ngm
NGM downgraded to Market Perform from Outperform at Raymond James
Report
NGM downgraded to Market Perform from Outperform at Raymond James
3/12
04:44 am
ngm
NGM downgraded to Market Perform from Outperform at Raymond James
Report
NGM downgraded to Market Perform from Outperform at Raymond James
2/29
07:35 am
ngm
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating.
Low
Report
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating.
2/29
07:35 am
ngm
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating.
Low
Report
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating.
2/27
09:17 am
ngm
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating.
Medium
Report
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating.